NICE guidance on nivolumab plus ipilimumab for untreated, unresectable malignant pleural mesothelioma

Lancet Respir Med. 2022 Oct;10(10):e92-e93. doi: 10.1016/S2213-2600(22)00301-0. Epub 2022 Aug 18.

¹ Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford OX3 7LE, UK. Electronic address: amanda.adler@dtu.ox.ac.uk.
² National Institute of Health and Care Excellence, Manchester and London, UK.
³ Bristol Medical School, University of Bristol, Bristol, UK.
⁴ Shrewton, Wiltshire, UK.
⁵ Welsh Health Specialised Services Committee, Pontypridd, UK.
⁶ National Institute of Health and Care Excellence, Manchester and London, UK; Addenbrooke's Hospital, Cambridge, UK.

No abstract available

Publication types